204 related articles for article (PubMed ID: 28715157)
1. Use of the ShangRing circumcision device in boys below 18 years old in Kenya: results from a pilot study.
Awori QD; Lee RK; Li PS; Moguche JN; Ouma D; Sambai B; Goldstein M; Barone MA
J Int AIDS Soc; 2017 Jul; 20(1):21588. PubMed ID: 28715157
[TBL] [Abstract][Full Text] [Related]
2. Simplifying the ShangRing technique for circumcision in boys and men: use of the no-flip technique with randomization to removal at 7 days versus spontaneous detachment.
Barone MA; Li PS; Lee RK; Ouma D; Oundo M; Barasa M; Oketch J; Otiende P; Nyangweso N; Maina M; Kiswi N; Chirchir B; Goldstein M; Awori QD
Asian J Androl; 2019; 21(4):324-331. PubMed ID: 30520424
[TBL] [Abstract][Full Text] [Related]
3. Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial.
Awori Q; Li PS; Lee RK; Ouma D; Oundo M; Barasa M; Obura N; Mwamkita D; Simba R; Oketch J; Nyangweso N; Maina M; Kiswi N; Kirui M; Chirchir B; Goldstein M; Barone MA
PLoS One; 2019; 14(8):e0218066. PubMed ID: 31412032
[TBL] [Abstract][Full Text] [Related]
4. Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia.
Sokal DC; Li PS; Zulu R; Awori QD; Agot K; Simba RO; Combes S; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2014 Dec; 67(4):430-7. PubMed ID: 25162816
[TBL] [Abstract][Full Text] [Related]
5. Rollout of ShangRing circumcision with active surveillance for adverse events and monitoring for uptake in Kenya.
Odoyo-June E; Owuor N; Kassim S; Davis S; Agot K; Serrem K; Otieno G; Awori Q; Hines J; Toledo C; Laube C; Kisia C; Aoko A; Ojiambo V; Mwandi Z; Juma A; Kigen B
PLoS One; 2019; 14(9):e0222942. PubMed ID: 31557208
[TBL] [Abstract][Full Text] [Related]
6. No-flip ShangRing circumcision in 10-12 year old boys: Results from randomized clinical trials in Kenya.
Al Hussein Alawamlh O; Awori QD; Barone MA; Kim SJ; Goldstein M; Li PS; Lee RK
PLoS One; 2020; 15(5):e0233150. PubMed ID: 32442198
[TBL] [Abstract][Full Text] [Related]
7. Longer-Term Follow-Up of Kenyan Men Circumcised Using the ShangRing Device.
Feldblum PJ; Okech J; Ochieng R; Hart C; Kiyuka G; Lai JJ; Veena V
PLoS One; 2015; 10(9):e0137510. PubMed ID: 26367141
[TBL] [Abstract][Full Text] [Related]
8. Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.
Feldblum PJ; Zulu R; Linyama D; Long S; Nonde TJ; Lai JJ; Kashitala J; Veena V; Kasonde P
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S30-5. PubMed ID: 27331587
[TBL] [Abstract][Full Text] [Related]
9. Prospective Observational Study of the ShangRing Device for Adult Medical Male Circumcision in a Routine Clinical Setting in Malawi.
Feldblum PJ; Mwambula C; Selemani M; Long S; Telela DJ; Mwenyekonde E; Lai JJ; Veena V; Mbeya P
Afr J Reprod Health; 2016 Dec; 20(4):60-66. PubMed ID: 29566320
[TBL] [Abstract][Full Text] [Related]
10. Surgical Outcomes of Newly Trained ShangRing Circumcision Providers.
Awori QD; Lee RK; Li PS; Zulu R; Agot K; Combes S; Simba RO; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S13-7. PubMed ID: 27331584
[TBL] [Abstract][Full Text] [Related]
11. ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: a multicentre, non-inferiority, adaptive, randomised controlled trial.
Basourakos SP; Nang QG; Ballman KV; Al Awamlh OAH; Punjani N; Ho K; Barone MA; Awori QD; Ouma D; Oketch J; Christensen AE; Hellar A; Makokha M; Isangu A; Salim R; Lija J; Gray RH; Kiboneka S; Anok A; Kigozi G; Nakabuye R; Ddamulira C; Mulooki A; Odiya S; Nazziwa R; Goldstein M; Li PS; Lee RK
Lancet Glob Health; 2022 Oct; 10(10):e1514-e1522. PubMed ID: 36113534
[TBL] [Abstract][Full Text] [Related]
12. Choosing the appropriate ShangRing size for paediatric circumcision using the no-flip technique.
Fang L; Zhu W; Xie Z; Wu K; Wang G; Yan Z; Zheng Z; Ma Q; Cheng Y
J Paediatr Child Health; 2018 Jan; 54(1):42-48. PubMed ID: 28799669
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis on the outcomes in circumcising children using modified Chinese ShangRing and conventional surgical circumcision.
Zhang Q; Gao L; Liu D; Song G; Gao P; Zhang S; Zhang J; Xu Y; Han D; Xu Y
Pediatr Surg Int; 2022 Dec; 39(1):59. PubMed ID: 36550318
[TBL] [Abstract][Full Text] [Related]
14. Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions.
Hohlfeld A; Ebrahim S; Shaik MZ; Kredo T
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012250. PubMed ID: 33786810
[TBL] [Abstract][Full Text] [Related]
15. Men's Understanding of and Experiences During the Postcircumcision Abstinence Period: Results From a Field Study of ShangRing Circumcision During Routine Clinical Services in Kenya and Zambia.
Barone MA; Li PS; Zulu R; Awori QD; Agot K; Combes S; Simba RO; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Sokal DC
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S18-23. PubMed ID: 27331585
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of a Pilot Intervention of Voluntary Medical Male Circumcision and HIV Education for Street-Connected Youth in Western Kenya.
Kibel M; Shah P; Ayuku D; Makori D; Kamaara E; Choge E; Nyairo J; Abuya P; Wahome M; Wachira J; Braitstein P
J Adolesc Health; 2019 Jan; 64(1):43-48. PubMed ID: 30327277
[TBL] [Abstract][Full Text] [Related]
17. Voluntary Medical Male Circumcision to Prevent HIV in Tanah Papua, Indonesia: Field Trial to Assess Acceptability and Feasibility.
Ansari MR; Lazuardi E; Wignall FS; Karma C; Sumule SA; Tarmizi SN; Magnani R
Curr HIV Res; 2017 Nov; 15(5):361-371. PubMed ID: 28990535
[TBL] [Abstract][Full Text] [Related]
18. The Shang Ring device for adult male circumcision: a proof of concept study in Kenya.
Barone MA; Ndede F; Li PS; Masson P; Awori Q; Okech J; Cherutich P; Muraguri N; Perchal P; Lee R; Kim HH; Goldstein M
J Acquir Immune Defic Syndr; 2011 May; 57(1):e7-12. PubMed ID: 21346586
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of the PrePex Male Circumcision Device: Results From Pilot Implementation Studies in Mozambique, South Africa, and Zambia.
Feldblum P; Martinson N; Bvulani B; Taruberekera N; Mahomed M; Chintu N; Milovanovic M; Hart C; Billy S; Necochea E; Samona A; Mhazo M; Bossemeyer D; Lai JJ; Lebinai L; Ashengo TA; Macaringue L; Veena V; Hatzold K
J Acquir Immune Defic Syndr; 2016 Jun; 72 Suppl 1(Suppl 1):S43-8. PubMed ID: 27331589
[TBL] [Abstract][Full Text] [Related]
20. Field evaluation of the safety, acceptability, and feasibility of early infant male circumcision using the AccuCirc device.
Bailey RC; Nyaboke I; Mackesy-Amiti ME; Okello E; Pengo V; Ochomo B; Auma ME; Were S; Ojuok S; Adoyo E; Adhiambo M; Young MR; Plank RM; Otieno FO
PLoS One; 2018; 13(2):e0191501. PubMed ID: 29444116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
